Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Recap is a cryptocurrency portfolio tracking, analytics and tax reporting platform. The company claims that market participants engaging in cryptocurrency have to deal with complex issues such as tracking all of their transactions, valuing cryptocurrency transactions in their tax currency and understanding capital gains tax legislation laws. Recap aims to solve this issue by enabling said participants to calculate any tax they owe on their cryptocurrency trading activity in a matter of seconds on its portal. The company has plans to launch a mobile application enabling investors to track their portfolio on the move. It also intends to come up with a Business-to-business (B2B) offering which Recap asserts will enable crypto native companies to account for their cryptocurrency activity with automatic accounts reconciliation to accounting software like Xero and Quickbooks. The company’s exit strategy is a trade sale within 3-5 years to a cryptocurrency exchange or accounting software provider.
days to go:
Expired
investment:
£120,472
Bippit is a wellbeing platform that provides employees with financial consultancy from a professional with zero cost to the employees themselves. The company asserts that COVID-19 has made financial consultancy services difficult to access for employees. Bippit aims to resolve this situation. It is available in mobile and desktop formats and integrates with an employees’ entire financial life through 'Open Banking'. Bippit argues that this helps staff members receive all the tools they need to learn, plan, and take action concerning their finances. It also helps companies save time and money, ensures that employees receive an impartial support system, and allows financial experts to get an extra revenue stream. The company will launch an Initial Public Offering (IPO) likely within 5 years if it moves beyond strategic acquisition.
days to go:
Expired
investment:
£73,000
Enertor is a sole manufacturer which uses smart material that cushions the foot when moved slowly, but on impact locks together to absorb and disperse energy, before instantly returning to its flexible state which reduces the risk of injury. The global orthotics market is worth $ 6.5 Billion per annum, of which approximately $ 3.5 Billion is foot orthotics and growing at 7% CAGR per annum. The company is on a mission to help everyone stay injury-free with their shock-absorbing insoles. They have strong endorsements from elite athletes, including Usain Bolt & the British Military. Their shock-absorbing insoles are to be mandated by the British Armed Forces, including the Royal Marines and SAS. With the proceeds, the company will develop its website, further research and development, IP protection and patent filing, marketing and working capital for the business.
days to go:
Expired
investment:
£509,999
Solent Automation specialises in developing, deploying and supporting automation robots to perform and tackle common manual labour-intensive tasks in factories. To solve the 'pick-and-place' challenges in an industrial setup, these robots are created with proven reliable components coupled with proprietary software to solve 'pick-and-place' challenges in an industrial environment. Two of the company's noteworthy products are 'SOLPAL 8' and 'SOLPACK 1XP, both are equipped with an all-in-one gripping tool, and can handle 16 boxes per minute and 60 packs per minute, respectively. Backed by a team of experts from manufacturing and robotics, Solent Automation provides on-site installation, training, and remote support for its products. There is also a rent-to-buy option through a 3rd party finance company. With the investment, the company aims at providing more robotic equipment most needed in factories focused on labour-intensive work functions.
days to go:
Expired
investment:
£76,000
FinOptix is an innovative FinTech company that solves real business problems. FinOptix’s objective is to become a significant player in a rapidly growing FinTech market by developing systems that provide financial clarity to decision-makers. FinOptix has a well-established user base, as well as a sales pipeline that covers multiple geographies and sectors. Their verification and validation procedures applied during the development process and operational trials have led to engagement with commercial partners. With the proceeds, they will design an Evaluator for the future, apply AI techniques to solve complex problems, develop their skill set and framework and hire a team of data scientists based on the assessment.
days to go:
Expired
investment:
£125,000
